authors
- Ji, Niannian
- Dennett, Ryan
- Curiel, Tyler J
- Svatek, Robert S
- Mukherjee, Neelam
- Reyes, Ryan M
- Gelfond, Jonathan
- Javors, Martin
- Meeks, Joshua J
- McConkey, David J
- Shu, Zhen-Ju
- Ramamurthy, Chethan
Rapamycin enhances BCG-specific γδ T cells during intravesical BCG therapy for non-muscle invasive bladder cancer: a randomized, double-blind study.
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- January 1, 2021
published in
has subject area
- Adjuvants, Immunologic
- Administration, Intravesical
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- BCG Vaccine
- Cytokines
- Double-Blind Method
- Female
- Humans
- Intraepithelial Lymphocytes
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Invasiveness
- Neoplasm Staging
- Phenotype
- Sirolimus
- Time Factors
- Treatment Outcome
- Tumor Microenvironment
- Urinary Bladder Neoplasms
- Urine